Sort
34,240 grants matching “atherosclerosis”
Atherogenic Patheways Mediated by FOXO
$543,434Domenico Accili · Columbia University Health Sciences · P01 · FY2009 · HL
The role of mTOR inhibition on longevity and healthy aging in a non-human primate
$543,394Adam Salmon · University Of Texas Hlth Science Center · R01 · FY2015 · AG
The role of mTOR inhibition on longevity and healthy aging in a non-human primate
$543,394Adam Salmon · University Of Texas Hlth Science Center · R01 · FY2017 · AG
The role of mTOR inhibition on longevity and healthy aging in a non-human primate
$543,394Adam Salmon · University Of Texas Hlth Science Center · R01 · FY2016 · AG
Endovascular Magnetic Catheter for Interventional MRI
$543,353Steven William Hetts · University Of California, San Francisco · R01 · FY2011 · EB
The UPR and CaMKIIg in Atherosclerosis and Insulin Resistance
$543,352Ira A Tabas · Columbia University Health Sciences · P01 · FY2017 · HL
The UPR and CaMKIIg in Atherosclerosis and Insulin Resistance
$543,352Ira A Tabas · Columbia University Health Sciences · P01 · FY2016 · HL
The UPR and CaMKIIg in Atherosclerosis and Insulin Resistance
$543,351Ira A Tabas · Columbia University Health Sciences · P01 · FY2013 · HL
Diabetes Prevention Program Outcome Study - Phase 2
$543,233David M Nathan · Massachusetts General Hospital · U01 · FY2009 · DK
GLUCOSE, INSULIN IN DIABETIC VASCULAR DISEASE
$543,171Klaus F. Ley · La Jolla Institute For Immunology · P01 · FY2010 · HL
Poor sense of smell and the health of older adults
$543,100Honglei Chen · Michigan State University · R01 · FY2023 · AG
Novel mechanisms of age-enhanced vasculopathy after heart transplantation
$543,089Daniel Robert Goldstein · University Of Michigan At Ann Arbor · R01 · FY2020 · AI
Novel mechanisms of age-enhanced vasculopathy after heart transplantation
$543,089Daniel Robert Goldstein · University Of Michigan At Ann Arbor · R01 · FY2021 · AI
Lymphocytes, Cholesterol, and Atherosclerosis
$543,044Catherine C Hedrick · La Jolla Institute For Immunology · P01 · FY2014 · HL
Role of platelet- monocyte interaction in promoting pro-atherogenic state in HIV-infected individuals
$542,978Juilee Thakar · University Of Rochester · R01 · FY2022 · HL
DNA methylation & adversity: pathways from exposures to health inequities
$542,971Nancy Krieger · Harvard School Of Public Health · R01 · FY2021 · MD
Integrative Cardiovascular Pathophysiology
$542,960Steven R Houser · Temple Univ Of The Commonwealth · T32 · FY2021 · HL
PROTEASE INHIBITOR RELATED DYSLIPIDEMIA
$542,750Tufts University Boston · R01 · FY2003 · HL
PROTEASE INHIBITOR RELATED DYSLIPIDEMIA
$542,750Tufts University Boston · R01 · FY2002 · HL
PROTEASE INHIBITOR RELATED DYSLIPIDEMIA
$542,750Tufts University Boston · R01 · FY2001 · HL
PROTEASE INHIBITOR RELATED DYSLIPIDEMIA
$542,750Tufts University Boston · R01 · FY2000 · HL
PROTEASE INHIBITOR RELATED DYSLIPIDEMIA
$542,750Tufts University Boston · R01 · FY2004 · HL
Subclinical CVD in African American Type 2 Diabetics
$542,725Barry Ira Freedman · Wake Forest University Health Sciences · R01 · FY2007 · DK
Accelerated CV Aging in Youth Related to CV Risk Factor Clusters
$542,621Elaine Mott Urbina · Cincinnati Childrens Hosp Med Ctr · R01 · FY2014 · HL
Regulation of cytosolic pattern recognition receptor signaling in macrophages
$542,613Christian Stehlik · Cedars-Sinai Medical Center · R01 · FY2020 · AI